Vascular emergencies from cosmetic filler-induced vascular occlusion represent an iatrogenic etiology that poses a threat to patients, with sequelae that range from disfiguring skin necrosis to blindness and stroke. As cosmetic fillers continue to grow in popularity, the importance of early identification, triaging, and management of these rare but potentially disabling injuries has motivated efforts to educate the public and professional audiences. In this practice review article, we outline components of acute care pertaining to these injuries based on evolving practice guidelines and best evidence recommendations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.annemergmed.2023.07.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vision recovery after ocular massage for cosmetic filler-induced ophthalmic artery occlusion.
Am J Ophthalmol Case Rep
December 2024
Shiley Eye Institute, University of California San Diego, San Diego, CA, USA.
Purpose: To report a case of vision recovery after ocular massage for cosmetic filler-induced ophthalmic artery occlusion.
Observations: A 58-year-old female experienced acute loss of vision of the left eye, left ptosis, and left glabellar skin discoloration immediately after cosmetic filler injection, suggestive of occlusion of the branches of the ophthalmic artery. Highly aggressive, prolonged ocular massage was initiated soon after and followed by a substantial recovery of vision.
Dermal Filler-Induced Alopecia: A Case Report and Literature Review.
J Cosmet Dermatol
November 2024
Department of Dermatology, King Fahad Medical City, Riyadh, Saudi Arabia.
Background: Dermal filler-induced alopecia is a rare yet significant complication of aesthetic procedures primarily associated with vascular occlusion and subsequent tissue ischemia. Hyaluronic acid (HA) fillers, though widely used for facial rejuvenation, can lead to adverse outcomes such as skin necrosis and hair loss, particularly in high-risk areas like the temples and glabella.
Objective: This case report aims to highlight the clinical presentation, diagnostic approach, and multidisciplinary management of filler-induced alopecia, contributing to the existing literature with a comprehensive review of previously reported cases.
Reply to: "Intralesional hyaluronidase injection to relieve non-hyaluronic acid filler-induced vascular adverse events".
Int J Dermatol
October 2024
King's College, Institute of Pharmaceutical Science, London, UK.
Intralesional hyaluronidase injection to relieve non-hyaluronic acid filler-induced vascular adverse events.
Int J Dermatol
September 2024
Department of Dermatology, Erasmus Medical Centre, Rotterdam, the Netherlands.
Background: Vascular adverse events (VAEs) occurring during injections of soft-tissue fillers are still considered a challenging issue for both patients and practitioners. Hyaluronidase can dissolve hyaluronic acid (HA)-based soft-tissue fillers during a VAE. For VAEs induced by non-HA fillers, the absence of an "antidote" is regarded as exceptionally challenging.
View Article and Find Full Text PDFInjecting soft-tissue fillers, such as hyaluronic acid, has become an extremely popular method of facial augmentation. Although rare, adverse effects, ranging from cosmetically dissatisfactory to dangerous, may occur. The most severe adverse effect of these is vascular occlusion of the central retinal artery, resulting in vision loss.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!